For instance, the influence of non-coding RNAs, metabolism, gut microbiome, and CSCs on the development of CRC, as well as the reciprocal interactions of these factors with aspirin and PIK3CA mutations in the context of CRC, has long been overlooked and show promising potential in providing answers and novel treatment targets. This evidence concerns the gene PIK3CA and colorectal carcinoma.